Global Digital Twins Market 2022 to 2035: Players Include Babylon, ExactCure, ImmersiveTouch and Navv Systems - Yahoo Finance

Company Logo

Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Digital Twins Market by Therapeutic Area, Type of Digital Twin, Area of Application, End Users and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" study has been added to ResearchAndMarkets.com's offering.

This study features an extended survey of the existent landscape, offering an informed sentiment connected the apt adoption of integer twins successful the healthcare domain, till 2035. The study features an in-depth analysis, highlighting the capabilities of assorted stakeholders engaged successful this marketplace space.

The probe and improvement down a caller cause is reported to require, connected an average, an concern of astir USD 1 billion. At present, implicit 90% of the cause candidates neglect crossed antithetic stages of objective trials, starring to important fiscal losses for developers.

In caller years, with the instauration of manufacture 4.0 technologies, specified arsenic augmented reality, large data, net of things (IoT) and virtual reality, the integer twins exertion has emerged arsenic a promising attack to mitigate a fig of the aforementioned healthcare related concerns.

Digital Twins notation to the virtual exemplary of a carnal object, process oregon service; specified models are capable to replicate real-life processes successful bid to cod real-time information to foretell their performance. Further, integer twins person been shown to gait up the objective trials and simulate studies for a larger population, successful overmuch quicker timelines. I

n fact, a radical of researchers engaged successful the classification of cause risks utilizing integer twins assertion that an extended mentation of the exemplary could assistance prevention up to USD 2.5 cardinal spent connected plan and investigating caller drugs. Several integer twins person been recovered to beryllium reliable successful the diagnosis / attraction of assorted diseases and are, hence, expected to trim the excessive outgo spent connected mendacious aesculapian diagnosis.

It is worthy mentioning that, connected an yearly basis, aesculapian errors are expected to pb to a nonaccomplishment of astir USD 20 cardinal successful the US. Therefore, integer twins are believed to person the imaginable to alteration important outgo savings. As a result, astir 15% of organizations that instrumentality IoT projects person already started utilizing integer duplicate platforms, portion implicit 60% of the firms are either readying oregon successful the process of establishing integer duplicate technologies successful their processes, successful the adjacent future.

Digital duplicate exertion companies are presently engaged successful the improvement of products which are intended for galore applications, specified arsenic plus / process management, personalized attraction and surgical planning. Additionally, arsenic mentioned earlier, a fig of integer duplicate platforms person been recovered reliable successful respective healthcare applications, specified arsenic diagnosis, wellness monitoring and aesculapian training.

The increasing involvement successful this marketplace tin besides beryllium validated from that information that, successful the past 2 years, adjacent to USD 6 cardinal has been invested by respective investors based crossed the globe, successful companies engaged successful the improvement oregon those offering integer twins. Interestingly, the concern enactment successful the manufacture has besides witnessed a maturation complaint of implicit 15%, successful the past 3 years. It is besides important to enactment that, implicit the past fewer years, determination person been a important innovation successful this marketplace space.

For instance, successful September 2022, European Medicines Agency (EMA) released a favorable qualification sentiment for TwinRCTT solution, for implementation successful AI-generated prognostic integer twins being evaluated successful signifier II and signifier III objective trials. Considering the continuous innovation related to integer twins and a increasing involvement successful automation and prognostic systems, we judge the integer duplicate marketplace size is apt to germinate astatine a accelerated pace, implicit the coming years.

Frequently Asked Questions

• What are integer twins?

• Who are the starring players engaged successful the improvement of integer twins for the healthcare domain?

• Which benignant of integer duplicate is astir commonly offered by developers engaged successful this marketplace space?

• What is the comparative competitiveness of antithetic players engaged successful the integer twins domain?

• What is the apt valuation of start-ups progressive successful the improvement of integer twins for the healthcare sector?

• What is the contiguous and apt aboriginal request for integer twins successful the wide healthcare sector?

• What are the anticipated aboriginal trends related to integer twins successful the healthcare domain?

• How is the existent and aboriginal accidental apt to beryllium distributed crossed cardinal marketplace segments?

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Digital Twins successful Healthcare: Overall Market Landscape
4.2.1. Analysis by Status of Development
4.2.2. Analysis by Therapeutic Area
4.2.3. Analysis by Area(s) of Application
4.2.4. Analysis by Type of Technology Used
4.2.5. Analysis by End User
4.2.6. Analysis by Type of Digital Twin
4.3. Digital Twins successful Healthcare: Developers Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters

5. KEY INSIGHTS
5.1. Chapter Overview
5.2. Analysis by Area of Application and Status of Development (Stacked Bar Chart)
5.3. Analysis by Type of Technology Used and Type of Digital Twin (Heat Map Representation)
5.4. Analysis by Type of End User and Type of Digital Twin (Grid Representation)
5.5. Analysis by Area of Application and Location of Headquarters (Bar Chart)
5.6. Analysis by Company Size and Location of Headquarters (Hybrid Chart)

6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Assumptions and Key Parameters
6.3. Methodology
6.4. Digital Twins successful Healthcare: Company Competitiveness Analysis
6.4.1. Company Competitiveness Analysis: Benchmarking of Portfolio Strength
6.4.2. Company Competitiveness Analysis: Benchmarking of Partnership Activity
6.4.3. Company Competitiveness Analysis: Benchmarking of Funding Activity
6.4.4. Company Competitiveness Analysis: Very Small Companies
6.4.5. Company Competitiveness Analysis: Small Companies
6.4.6. Company Competitiveness Analysis: Mid-sized Companies
6.4.7. Company Competitiveness Analysis: Large Companies
6.4.8. Company Competitiveness Analysis: Very Large Companies

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Babylon
7.2.1. Company Overview
7.2.2. Recent Developments and Future Outlook
7.3. ExactCure
7.3.1. Company Overview
7.3.2. Recent Developments and Future Outlook
7.4. ImmersiveTouch
7.4.1. Company Overview
7.4.2. Recent Developments and Future Outlook
7.5. Navv Systems
7.5.1. Company Overview
7.5.2. Recent Developments and Future Outlook
7.6. ThoughtWire
7.6.1. Company Overview
7.6.2. Recent Developments and Future Outlook
7.7. Unlearn.AI
7.7.1. Company Overview
7.7.2. Recent Developments and Future Outlook

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Digital Twins successful Healthcare: Partnerships and Collaborations
8.2.1. Partnership Models
8.2.2. List of Partnerships and Collaborations
8.2.3. Analysis by Number of Partnership Instances
8.2.4. Analysis by Type of Partnership
8.2.5. Analysis by Year and Type of Partnership
8.2.6. Analysis by Type of Partnership and Company Size
8.2.7. Most Active Players: Analysis by Number of Partnerships
8.3.8. Analysis by Region
8.3.9. Intercontinental and Intracontinental Agreements

9. FUNDING AND INVESTMENTS ANALYSIS
9.1. Chapter Overview
9.2. Types of Funding
9.3. Digital Twins successful Healthcare: List of Funding and Investments
9.3.1. Analysis by Number of Funding Instances
9.3.2. Analysis by Amount Invested
9.3.3. Analysis by Type of Funding
9.3.4. Analysis by Geography
9.3.5. Most Active Players: Analysis by Number of Funding Instances
9.3.6. Most Active Players: Analysis by Amount of Funding
9.3.7. Most Active Investors: Analysis by Number of Funding Instances
9.4. Concluding Remarks

10. BERKUS START-UP VALUATION ANALYSIS
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Berkus Start-Up Valuation: Total Valuation of Players
10.4. Digital Twins successful Healthcare: Benchmarking of Berkus Start-Up Valuation Parameters
10.4.1. AnatoScope: Benchmarking of Berkus Start-Up Valuation Parameters
10.4.2. ExactCure: Benchmarking of Berkus Start-Up Valuation Parameters
10.4.3. Klinik Sankt Moritz: Benchmarking of Berkus Start-Up Valuation Parameters
10.4.4. KYDEA: Benchmarking of Berkus Start-Up Valuation Parameters
10.4.5. TwInsight: Benchmarking of Berkus Start-Up Valuation Parameters
10.4.6. Yokogawa Insilico Biotechnology: Benchmarking of Berkus Start-Up Valuation Parameters
10.5. Digital Twins successful Healthcare: Benchmarking of Players
10.5.1. Sound Idea: Benchmarking of Players
10.5.2. Prototype: Benchmarking of Players
10.5.3. Management Experience: Benchmarking of Players
10.5.4. Strategic Relationships: Benchmarking of Players
10.5.5. Total Valuation: Benchmarking of Players

11. MARKET FORECAST
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Global Digital Twins Market, 2022-2035
11.3.1. Global Digital Twins Market: Analysis by Therapeutic Area
11.3.1.1. Global Digital Twins Market for Cardiovascular Disorders, 2022-2035
11.3.1.2. Global Digital Twins Market for Metabolic Disorders, 2022-2035
11.3.1.3. Global Digital Twins Market for Orthopedic Disorders, 2022-2035
11.3.1.4. Global Digital Twins Market for Other Disorders, 2022-2035
11.3.2. Global Digital Twins Market: Analysis by Type of Digital Twins
11.3.2.1. Global Process Twins Market, 2022-2035
11.3.2.2. Global System Twins Market, 2022-2035
11.3.2.3. Global Whole Body Twins Market, 2022-2035
11.3.2.4. Global Body Part Twins Market, 2022-2035
11.3.3. Global Digital Twins Market: Analysis by Area of Application
11.3.3.1. Global Digital Twins Market for Asset / Process Management, 2022-2035
11.3.3.2. Global Digital Twins Market for Personalized Treatment, 2022-2035
11.3.3.3. Global Digital Twins Market for Surgical Planning, 2022-2035
11.3.3.4. Global Digital Twins Market for Diagnosis, 2022-2035
11.3.3.5. Global Digital Twins Market for Other Applications, 2022-2035
11.3.4. Global Digital Twins Market: Analysis by End Users
11.3.4.1. Global Digital Twins Market for Pharmaceutical Companies, 2022-2035
11.3.4.2. Global Digital Twins Market for Medical Device Manufacturers, 2022-2035
11.3.4.3. Global Digital Twins Market for Healthcare Providers, 2022-2035
11.3.4.4. Global Digital Twins Market for Patients, 2022-2035
11.3.4.5. Global Digital Twins Market for Other End Users, 2022-2035
11.3.5. Global Digital Twins Market: Analysis by Geography
11.3.5.1. Digital Twins Market successful North America, 2022-2035
11.3.5.2. Digital Twins Market successful Europe, 2022-2035
11.3.5.3. Digital Twins Market successful Asia, 2022-2035
11.3.5.4. Digital Twins Market successful Latin America, 2022-2035
11.3.5.5. Digital Twins Market successful Middle East and North Africa, 2022-2035
11.3.5.6. Digital Twins Market successful Rest of the World, 2022-2035

12. CONCLUSION

13. EXECUTIVE INSIGHTS
13.1. Chapter Overview
13.2. Dassault Systemes
13.2.1. Company Snapshot
13.2.2. Interview Transcript: Barbara Holtz, Business Consultant
13.3. TwInsight
13.3.1. Company Snapshot
13.3.2. Interview Transcript: Marek Bucki, Co-Founder and Chief Scientific Officer
13.4. Unlearn.AI
13.4.1. Company Snapshot
13.4.2. Interview Transcript: Andrew Stelzer, Business Development Executive
13.5. Yokogawa Insilico Biotechnology
13.5.1. Company Snapshot
13.5.2. Interview Transcript: Klaus Mauch, Managing Director and Chief Executive Officer

14. APPENDIX I: TABULATED DATA

15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

For much accusation astir this study sojourn https://www.researchandmarkets.com/r/v6vkv7

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900